Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Low frequency of HPV positivity in breast tumors among patients from south-central Poland.
Biesaga B, Janecka-Widła A, Kołodziej-Rzepa M, Mucha-Małecka A, Słonina D, Ziobro M, Wysocka J, Adamczyk A, Majchrzyk K, Niemiec J, Ambicka A, Grela-Wojewoda A, Harazin-Lechowska A. Biesaga B, et al. Among authors: majchrzyk k. Infect Agent Cancer. 2021 Nov 27;16(1):67. doi: 10.1186/s13027-021-00405-z. Infect Agent Cancer. 2021. PMID: 34838092 Free PMC article.
Proteins Involved in HER2 Signalling Pathway, Their Relations and Influence on Metastasis-Free Survival in HER2-Positive Breast Cancer Patients Treated with Trastuzumab in Adjuvant Setting.
Adamczyk A, Grela-Wojewoda A, Domagała-Haduch M, Ambicka A, Harazin-Lechowska A, Janecka A, Cedrych I, Majchrzyk K, Kruczak A, Ryś J, Niemiec J. Adamczyk A, et al. Among authors: majchrzyk k. J Cancer. 2017 Jan 1;8(1):131-139. doi: 10.7150/jca.16239. eCollection 2017. J Cancer. 2017. PMID: 28123607 Free PMC article.
Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment.
Adamczyk A, Kruczak A, Harazin-Lechowska A, Ambicka A, Grela-Wojewoda A, Domagała-Haduch M, Janecka-Widła A, Majchrzyk K, Cichocka A, Ryś J, Niemiec J. Adamczyk A, et al. Among authors: majchrzyk k. Onco Targets Ther. 2018 Aug 3;11:4525-4535. doi: 10.2147/OTT.S166983. eCollection 2018. Onco Targets Ther. 2018. PMID: 30122944 Free PMC article.
BGX-Ki-67 index as a supplementary marker to MIB-1 index, enabling more precise distinction between luminal A and B subtypes of breast carcinoma and eliminating the problem of membranous/cytoplasmic MIB-1 staining.
Niemiec J, Adamczyk A, Ambicka A, Mucha-Małecka A, Wysocki WM, Majchrzyk K, Ryś J. Niemiec J, et al. Among authors: majchrzyk k. Am J Clin Pathol. 2015 Mar;143(3):419-29. doi: 10.1309/AJCPHAEK82QWQORJ. Am J Clin Pathol. 2015. PMID: 25696801
Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting.
Adamczyk A, Niemiec J, Janecka A, Harazin-Lechowska A, Ambicka A, Grela-Wojewoda A, Domagała-Haduch M, Cedrych I, Majchrzyk K, Kruczak A, Ryś J, Jakubowicz J. Adamczyk A, et al. Among authors: majchrzyk k. Pol J Pathol. 2015 Jun;66(2):133-41. doi: 10.5114/pjp.2015.53009. Pol J Pathol. 2015. PMID: 26247526 Free article.
11 results